3059-4057

Cardiovascular Diabetology – Endocrinology Reports

Springer (Biomed Central Ltd.)

View prefix report (10.1186)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 63 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact63 DOIs
2

Add abstracts to 60 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact60 DOIs
3

Deposit reference lists for 2 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact2 DOIs

DOIs for this ISSN

Showing the top 5 of 92 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Cluster analysis reveals distinct inflammatory phenotypes in… (10.1186/s40842-025-00227-7)
Abstract ORCID
45.15 7
2 Hypertension in type 2 diabetes mellitus: prevalence, patter… (10.1186/s40842-025-00225-9)
Abstract ORCID
34.95 4
3 The heart of diabetes: unraveling metabolic drivers of cardi… (10.1186/s40842-025-00231-x)
Abstract ORCID
34.95 4
4 Cardiometabolic risk reduction with digital twinning in pati… (10.1186/s40842-025-00242-8)
Abstract ORCID
34.95 4
5 Epidemiology of cardiovascular disease and diabetes in 2026:… (10.1186/s40842-026-00283-7)
Abstract ORCID
34.95 4
6 Bromocriptine in type 2 diabetes: a promising alternative, a… (10.1186/s40842-025-00222-y)
Abstract ORCID
30.10 3
7 Aging, biofilms, and diabetic foot ulcers: disrupting chroni… (10.1186/s40842-025-00261-5)
Abstract ORCID
30.10 3
8 Effectiveness of SGLT2 inhibitors, incretin-based therapies,… (10.1186/s40842-025-00248-2)
ORCID
26.98 11
9 The effects of diabetes on the glymphatic system: recent adv… (10.1186/s40842-024-00211-7)
Abstract ORCID
23.86 2
10 The 2025 AHA/ACC hypertension guidelines: implications for c… (10.1186/s40842-025-00239-3)
ORCID
23.86 8
11 Effect of tofogliflozin on cardiac sympathetic nerve activit… (10.1186/s40842-025-00260-6)
Abstract ORCID
23.86 2
12 Association of hemoglobin glycation index with the severity… (10.1186/s40842-025-00262-4)
Abstract ORCID
23.86 2
13 Correction: Effect of liraglutide biosimilar vs. reference l… (10.1186/s40842-025-00233-9)
Abstract References ORCID
22.58 1
14 Relationship between type II diabetes mellitus and oral heal… (10.1186/s40842-024-00205-5)
Abstract
17.47 4
15 Diabetes mellitus in Pakistan: prevalence and preventive man… (10.1186/s40842-025-00235-7)
Abstract
17.47 4
16 Real-world prescriptions of GLP-1RAs and SGLT2is in type 2 d… (10.1186/s40842-025-00251-7)
Abstract
17.47 4
17 DPP4 inhibitors and COVID19 outcomes in patients with type I… (10.1186/s40842-025-00221-z)
Abstract ORCID
15.05 1
18 Sex differences in ventricular muscle energetics in a type 2… (10.1186/s40842-025-00236-6)
Abstract ORCID
15.05 1
19 Prognostic impact of proteinuria in diabetic patients withou… (10.1186/s40842-025-00243-7)
Abstract ORCID
15.05 1
20 From needles to pills: oral GLP-1 therapy enters the obesity… (10.1186/s40842-025-00245-5)
ORCID
15.05 3
21 SGLT2 inhibitors in cardiac amyloidosis: mechanistic insight… (10.1186/s40842-025-00252-6)
Abstract
15.05 3
22 Impact of medication therapy management intervention on medi… (10.1186/s40842-025-00254-4)
Abstract ORCID
15.05 1
23 Associations between novel triglyceride-glucose-related indi… (10.1186/s40842-025-00255-3)
ORCID
15.05 3
24 Autonomic-inflammatory crosstalk in diabetic atherogenesis:… (10.1186/s40842-025-00259-z)
Abstract ORCID
15.05 1
25 Lipid-based atherogenic indices and their relationship with… (10.1186/s40842-025-00269-x)
Abstract
15.05 3
26 From deep learning discovery to clinical validation: a new c… (10.1186/s40842-025-00229-5)
Abstract
11.93 2
27 Statins, skeletal muscle, and ryanodine receptor activation:… (10.1186/s40842-025-00267-z)
ORCID
11.93 2
28 A cross-sectional study to determinate the relationship betw… (10.1186/s40842-025-00216-w)
Abstract
7.53 1
29 An 18-year Odyssey: navigating the complex path of prolactin… (10.1186/s40842-025-00218-8)
ORCID
7.53 1
30 Effect of liraglutide biosimilar vs. reference liraglutide o… (10.1186/s40842-025-00219-7)
ORCID
7.53 1
31 Metabolomic signatures in adults with metabolic syndrome ind… (10.1186/s40842-025-00223-x)
ORCID
7.53 1
32 Factors related to reversal of prediabetes in patients from… (10.1186/s40842-025-00224-w)
Abstract
7.53 1
33 Metabolic syndrome and associated factors among benign prost… (10.1186/s40842-025-00226-8)
Abstract
7.53 1
34 Triple arm, prospective, real-world study comparing the effi… (10.1186/s40842-025-00244-6)
ORCID
7.53 1
35 Patterns of lipid profile and genetic variations in South As… (10.1186/s40842-025-00246-4)
Abstract
7.53 1
36 Differences in cardiovascular disease incidence according to… (10.1186/s40842-025-00249-1)
Abstract
7.53 1
37 Efficacy and safety of orforglipron, an oral small-molecule… (10.1186/s40842-025-00270-4)
ORCID
7.53 1
38 Effects of gestational diabetes mellitus and diabetes mellit… (10.1186/s40842-024-00206-4)
0.00 9
39 Response to long-term pharmacological management of metrelep… (10.1186/s40842-024-00207-3)
0.00 0
40 Managing type 2 diabetes during the COVID-19 pandemic in Gha… (10.1186/s40842-024-00213-5)
Abstract
0.00 0
41 Correction: Long-term TNF-alpha therapy for preserving beta… (10.1186/s40842-025-00217-9)
Abstract
0.00 0
42 Diazoxide as a bridging therapy in methadone-induced hypogly… (10.1186/s40842-025-00220-0)
0.00 2
43 Effect of cabergoline on the management of diabetes mellitus… (10.1186/s40842-025-00230-y)
Abstract ORCID
0.00 0
44 Non-diabetic hypoglycemia: bridging gaps in diagnosis and tr… (10.1186/s40842-025-00234-8)
0.00 2
45 Determinants of diabetic retinopathy among adult and elderly… (10.1186/s40842-025-00237-5)
Abstract ORCID
0.00 0
46 Clinical and functional outcomes of the silo technique in th… (10.1186/s40842-025-00238-4)
ORCID
0.00 0
47 Associations of cardiorespiratory fitness and muscle strengt… (10.1186/s40842-025-00240-w)
ORCID
0.00 0
48 Advanced age and elevated cholesterol predict diabetic neuro… (10.1186/s40842-025-00241-9)
ORCID
0.00 0
49 Chronic hyperglycemia and cardiovascular dysfunction: an in-… (10.1186/s40842-025-00247-3)
0.00 29
50 Missed opportunities in diabetes care: unraveling therapeuti… (10.1186/s40842-025-00250-8)
Abstract ORCID
0.00 0